Malcolm A. Smith

Also affiliated with National Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.448Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf214

Top 42%

0.448DataRank

Top 42%7 citations

Subhashini Jagu, Malcolm A. Smith, John Shern, Douglas S. Hawkins, Elaine R. Mardis +26 more

Papers

Driven by 20 papers — median percentile 29. Top paper: “Selumetinib in Children with Inoperable Plexiform Neurofibromas”.

Selumetinib in Children with Inoperable Plexiform Neurofibromas

New England Journal of Medicine(2020)10.1056/nejmoa1912735

N/A

9.0DataRank · unranked

708 citations

Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Patricia Whitcomb, Michael J. Fisher +24 more

Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas

Neuro-Oncology(2023)10.1093/neuonc/noad086

N/A

2.3DataRank · unranked

97 citations

Eva Dombi, Pamela L. Wolters, Andrea Baldwin, Anne Dufek, Kailey R. Herrera +14 more

Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity

Neuro-Oncology(2022)10.1093/neuonc/noac109

N/A

1.7DataRank · unranked

66 citations

Brittany Glassberg, Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Michael J. Fisher +18 more

Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid Tumors

Cancer Research(2023)10.1158/0008-5472.can-22-3186

N/A

0.562DataRank · unranked

11 citations

Gonzalo López, Karina L. Conkrite, Chun Su, Tsz Ching Leung, Sathvik Ramanan +15 more

Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0836

N/A

0.524DataRank · unranked

32 citations

Xiangjun Tian, Wendong Zhang, Zhongting Zhang, Rossana Lazcano, Pooja Hingorani +20 more

Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies

Laboratory Investigation(2021)10.1038/s41374-021-00700-8

N/A

0.494DataRank · unranked

26 citations

Holly B. Lindsay, Mari Kogiso, Yuchen Du, Frank Braun, Huiyuan Zhang +12 more

Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf214

Top 42%

0.448DataRank

Top 42%7 citations

Subhashini Jagu, Malcolm A. Smith, John Shern, Douglas S. Hawkins, Elaine R. Mardis +26 more

Testing of B7-H3 targeting antibody-drug conjugate (ADC) MGC018 in models of pediatric solid tumors by the Pediatric Preclinical Testing Consortium (PPTC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10037

N/A

0DataRank · unranked

9 citations

Yaël P. Mossé, Vanessa Del Pozo, Eric J. Earley, Stephen W. Erickson, David Groff +9 more

A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study

Neuro-Oncology(2021)10.1093/neuonc/noab047

N/A

0DataRank · unranked

159 citations

Arzu Onar‐Thomas, Tina Young Poussaint, Shengjie Wu, Azra H. Ligon, Neal I. Lindeman +18 more

Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3909

N/A

0DataRank · unranked

216 citations

Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Mitchell B. Diccianni, Jacek Gan +14 more

Somatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma

Genome Research(2020)10.1101/gr.252106.119

N/A

0DataRank · unranked

32 citations

Karina L. Conkrite, Miriam Doepner, Komal S. Rathi, Apexa Modi, Zalman Vaksman +13 more

Integrative genomics identifies lncRNA regulatory networks across 1,044 pediatric leukemias and extra-cranial solid tumors

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.10.420257

Top 100%

0DataRank

Top 100%0 citations

Gonzalo López, Karina L. Conkrite, Chun Su, Tsz Ching Leung, Sathvik Ramanan +16 more

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.06.570390

N/A

0DataRank · unranked

5 citations

Alexander B. Radaoui, Matthew Tsang, Daniel Martínez, Simone Sidoli, Karina L. Conkrite +31 more

Data from Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

(2023)10.1158/1078-0432.c.6531294

N/A

0DataRank · unranked

0 citations

Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Mitchell B. Diccianni, Jacek Gan +14 more

Data from Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

(2023)10.1158/1078-0432.c.6531294.v1

N/A

0DataRank · unranked

0 citations

Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Mitchell B. Diccianni, Jacek Gan +14 more

A genome-wide association analysis reveals new pathogenic pathways in gout

Nature Genetics(2024)10.1038/s41588-024-01921-5

N/A

0DataRank · unranked

85 citations

Riku Takei, Hirotaka Matsuo, Megan Leask, Nicholas A. Sumpter, Ruth Topless +94 more

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

Cancer Cell(2024)10.1016/j.ccell.2024.10.003

N/A

0DataRank · unranked

18 citations

Alexander B. Radaoui, Matthew Tsang, Daniel Martínez, Karina L. Conkrite, Khushbu Patel +33 more

Targeting fusion oncoproteins in childhood cancers: challenges and future opportunities for developing therapeutics

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae075

N/A

0DataRank · unranked

7 citations

Keren L. Witkin, Anu Sharman, Malcolm A. Smith, Sharad K. Verma

Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft models

Scientific Reports(2024)10.1038/s41598-024-69382-8

N/A

0DataRank · unranked

1 citations

Licai Huang, Zhongting Zhang, Zhenlin Ju, Xingzhi Song, E. Anders Kolb +14 more

Outcomes and toxicities in patients (pts) non-randomly assigned to immunotherapy Children’s Oncology Group (COG) ANBL0032.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10523

N/A

0DataRank · unranked

0 citations

Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Wendy B. London, Sheena C. Tenney +11 more

Malcolm A. Smith

Indexed papers

Top data-sharing exemplar

Papers